The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer-Reference-Cited by-同舟云学术

The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer

Published:2018-04-12 Issue:1 Volume:13 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Zamboglou Constantinos^ORCID,Klein Christina Marie,Thomann Benedikt,Fassbender Thomas Franz,Rischke Hans C.,Kirste Simon,Henne Karl,Volegova-Neher Natalja,Bock Michael,Langer Mathias,Meyer Philipp T.,Baltas Dimos,Grosu Anca L.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-018-1014-1.pdf

Reference30 articles.

1. Cooper CS, Eeles R, Wedge DC, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet. 2015;47(4):367–72.

2. Haffner MC, Mosbruger T, Esopi DM, et al. Tracking the clonal origin of lethal prostate cancer. J Clin Invest. 2013;123(11):4918–22.

3. Arrayeh E, Westphalen AC, Kurhanewicz J, et al. Does local recurrence of prostate Cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol. 2012;82(5):E787–E93.

4. Pucar D, Hricak H, Shukla-Dave A, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol. 2007;69(1):62–9.

5. Mendez LC, Ravi A, Chung H, et al. Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high dose-rate brachytherapy. Brachytherapy. 2018;17(2):291-7.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions – A systematic review and meta-analysis;Radiotherapy and Oncology;2024-03

2. ROLE OF CONTEMPORARY IMAGING METHODS IN RADIOTHERAPY PLANNING AND MONITORING OF GYNECOLOGICAL CANCER PATIENTS (REVIEW);Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology;2023

3. Prostate Cancer;Target Volume Definition in Radiation Oncology;2023

4. Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour;Clinical and Translational Radiation Oncology;2022-07

5. Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients;BMC Cancer;2022-03-28